Discontinued — last reported Q3 '22

Business Segments · Operating Income (Loss)

LabCorp Diagnostics — Operating Income (Loss)

Labcorp Holdings LabCorp Diagnostics — Operating Income (Loss) decreased by 16.9% to $378.70M in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 47.6%, from $722.70M to $378.70M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2022
Rolls up toOperating Income

How to read this metric

An increase signals improved operational efficiency, better cost management, or higher margins on diagnostic services.

Detailed definition

This metric measures the profitability of the diagnostics segment after deducting operating expenses such as labor, supp...

Peer comparison

Standard operating profit metric used across the healthcare services industry to benchmark segment performance.

Metric ID: lh_segment_labcorp_diagnostics_operating_income_loss

Historical Data

5 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22
Value$603.60M$722.70M$623.30M$455.50M$378.70M
QoQ Change+19.7%-13.8%-26.9%-16.9%
YoY Change-24.5%-47.6%
Range$378.70M$722.70M
CAGR-37.3%
Avg YoY Growth-36.1%
Median YoY Growth-36.1%
Current Streak3 quarters decline

Frequently Asked Questions

What is Labcorp Holdings's labcorp diagnostics — operating income (loss)?
Labcorp Holdings (LH) reported labcorp diagnostics — operating income (loss) of $378.70M in Q3 2022.
How has Labcorp Holdings's labcorp diagnostics — operating income (loss) changed year-over-year?
Labcorp Holdings's labcorp diagnostics — operating income (loss) decreased by 47.6% year-over-year, from $722.70M to $378.70M.
What does labcorp diagnostics — operating income (loss) mean?
The profit earned from core business operations after accounting for direct and indirect operating costs.